|Articles|January 1, 2019
- Pharmaceutical Executive-01-01-2019
- Volume 39
- Issue 1
Pharmaceutical Executive, January 2019 Issue (PDF)
Click the title above to open the Pharmaceutical January 2019 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 7 years ago
Ipsen’s David Meek: Tasked to Transformover 7 years ago
Drug Research and Review Issues on Radar at FDAover 7 years ago
Finding the Right Digital Health Partnerover 7 years ago
Future Pharma: Data Science as a Strategic Partnerover 7 years ago
Ascending the Uncanny Valley in Healthcareover 7 years ago
Country Report: TurkeyAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Beyond JAK Inhibitors: Biologics Signal a New Era in Alopecia Areata
2
Pharma M&A Roundup: Incyte to Acquire Vega Therapeutics, Galmed Pharmaceuticals to Acquire Colospan, Johnson & Johnson Acquires Firefly Bio
3
Chai Discovery Enters License Agreement with Pfizer to Accelerate Drug Discovery with AI
4
Roche Enters $2.3 Billion Global Collaboration with Nurix Therapeutics to Co-Develop and Co-Commercialize Bexobrutideg
5